Min Ho Lee1, In Jae Lee1, Tae Jin Kim1, Sang Chul Lee1, Chang Wook Jeong1, Sung Kyu Hong1, Seok-Soo Byun1, Jong Jin Oh2. 1. Department of Urology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 300, Gumi-dong, Bundang-gu, Seongnam, Gyeonggi-do, 463-707, South Korea. 2. Department of Urology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 300, Gumi-dong, Bundang-gu, Seongnam, Gyeonggi-do, 463-707, South Korea. bebsuzzang@naver.com.
Abstract
OBJECTIVES: To evaluate the effect of preoperative ureteral stenting duration on the outcomes of retrograde intrarenal surgery (RIRS). PATIENTS AND METHODS: We reviewed our database of patients who underwent RIRS between May 2011 and April 2017 at our institution. The patients were divided into three groups according to preoperative ureteral stenting duration: group 1: no stenting, group 2: short preoperative stenting (< 7 days) and group 3: long preoperative stenting (≥ 7 days). We compared the rate of ureteral injury, other perioperative complications, ureteral dilation and readmission, stone-free rate (SFR) and operative time among the groups. RESULTS: A total of 560 patients (215 in group 1, 177 in group 2 and 168 in group 3) were included in this study. The mean of maximum stone size was 13.1 (± 6.2) mm, the mean number of stones was 2.3 (± 1.9) and preoperative ureteral stenting duration was 7.2 (± 3.7) days. There were no significant differences in operative time (75.6, 78.5 and 82.4 min, p = 0.280), SFR (79.1, 84.2 and 81.0%, p = 0.433), ureteral injury rate (7.0, 5.1 and 2.4%, p = 0.123) and other perioperative complication rates (12.1, 6.8 and 6.0%, p = 0.061). The only one case of grade IV ureteral injury occurred in group 1 and the rate of ureteral dilation was significantly higher than in group 2 and 3 (14.9, 5.7 and 6.0%, p < 0.001). CONCLUSION: Although preoperative ureteral stenting duration has no significant effect on operative outcomes, it is an effective procedure for reducing the rate of intraoperative ureteral balloon dilation and preventing high-grade ureteral injuries.
OBJECTIVES: To evaluate the effect of preoperative ureteral stenting duration on the outcomes of retrograde intrarenal surgery (RIRS). PATIENTS AND METHODS: We reviewed our database of patients who underwent RIRS between May 2011 and April 2017 at our institution. The patients were divided into three groups according to preoperative ureteral stenting duration: group 1: no stenting, group 2: short preoperative stenting (< 7 days) and group 3: long preoperative stenting (≥ 7 days). We compared the rate of ureteral injury, other perioperative complications, ureteral dilation and readmission, stone-free rate (SFR) and operative time among the groups. RESULTS: A total of 560 patients (215 in group 1, 177 in group 2 and 168 in group 3) were included in this study. The mean of maximum stone size was 13.1 (± 6.2) mm, the mean number of stones was 2.3 (± 1.9) and preoperative ureteral stenting duration was 7.2 (± 3.7) days. There were no significant differences in operative time (75.6, 78.5 and 82.4 min, p = 0.280), SFR (79.1, 84.2 and 81.0%, p = 0.433), ureteral injury rate (7.0, 5.1 and 2.4%, p = 0.123) and other perioperative complication rates (12.1, 6.8 and 6.0%, p = 0.061). The only one case of grade IV ureteral injury occurred in group 1 and the rate of ureteral dilation was significantly higher than in group 2 and 3 (14.9, 5.7 and 6.0%, p < 0.001). CONCLUSION: Although preoperative ureteral stenting duration has no significant effect on operative outcomes, it is an effective procedure for reducing the rate of intraoperative ureteral balloon dilation and preventing high-grade ureteral injuries.
Authors: Jamil Rehman; Manoj Monga; Jaime Landman; David I Lee; Tamer Felfela; Marius C Conradie; Rajamahanty Srinivas; Chandru P Sundaram; Ralph V Clayman Journal: Urology Date: 2003-04 Impact factor: 2.649
Authors: Hsin-Hsiao Wang; Lin Huang; Jonathan C Routh; Paul Kokorowski; Barley G Cilento; Caleb P Nelson Journal: J Urol Date: 2011-08-19 Impact factor: 7.450
Authors: Brian K Auge; Paul K Pietrow; Costas D Lallas; Ganesh V Raj; Robert W Santa-Cruz; Glenn M Preminger Journal: J Endourol Date: 2004-02 Impact factor: 2.942
Authors: Adam E Perlmutter; Can Talug; William F Tarry; Stanley Zaslau; Hesam Mohseni; Stanley J Kandzari Journal: Urology Date: 2008-02 Impact factor: 2.649
Authors: Y X T Law; J Y C Teoh; D Castellani; E J Lim; E O T Chan; M Wroclawski; G M Pirola; C Giulioni; E Rubilotta; M Gubbioti; S Scarcella; B H Chew; O Traxer; B K Somani; V Gauhar Journal: World J Urol Date: 2022-01-24 Impact factor: 4.226